Welcome to our dedicated page for Scworx news (Ticker: WORX), a resource for investors and traders seeking the latest updates and insights on Scworx stock.
SCWorx Corp (NASDAQ: WORX) is a healthcare-focused software-as-a-service company that provides data management and interoperability solutions to hospitals, health systems, and related supply chain partners. Its news flow reflects activities around healthcare data management, SaaS platform development, and capital markets events.
Recent press releases highlight new customer wins and partnerships, including agreements with academic hospital organizations, large not-for-profit health systems, and aggregate purchasing groups. SCWorx reports that its solutions are used to support data cleanse and enrichment services, Workday ERP initiatives, and broader operational workflows within healthcare providers. The company also announces collaborations with healthcare supply chain and payment partners that use SCWorx data to enhance cost savings and expense management programs.
Investors following WORX news will find updates on product and platform developments, such as the use of an advanced attributed virtualized item data warehouse built with machine learning and artificial intelligence. The company’s communications also cover leadership changes, including technology leadership appointments intended to support its data platform and SaaS offerings.
In addition to operational and partnership news, SCWorx issues releases on financing transactions, Nasdaq listing status, and shareholder meetings. These include equity financings, warrant-related agreements, and notices regarding compliance with Nasdaq’s minimum bid price and reporting rules. Together, these items provide context on both the company’s business activities in healthcare data management and its ongoing obligations as a Nasdaq-listed issuer.
This news page aggregates these disclosures so readers can review SCWorx’s latest announcements on customers, partnerships, technology focus, financing, and corporate governance in one place.
SCWorx Corp (NASDAQ: WORX) has renewed and expanded a data service agreement with a hospital in New England, increasing the contract value to $200,000 per year over four years. The enhanced agreement will integrate data from the hospital's critical systems, enabling better data analysis and cost savings identification. SCWorx estimates that the partnership will help the hospital uncover over $3 million in annual savings and revenue capture. The company specializes in advanced data solutions for healthcare providers, focusing on operational efficiency and accurate benchmarking.
SCWorx Corp (NASDAQ: WORX) has extended its service agreement with a top-ranked Integrated Delivery Network (IDN) for two years. The new agreement, effective January 1, 2022, will increase the contract value to $960,000, with $135,000 recognized in Q1 2022. This extension includes additional services for Oracle Cloud, enhancing efficiency in healthcare operations. The CEO stated confidence in procuring new contracts and emphasized no significant additional overhead for the company.
SCWorx Corp. has entered a common stock purchase agreement with an institutional investor allowing the issuance of up to $5 million in common stock over 24 months. This agreement is intended to support SCWorx's growth strategy by enabling access to funds for working capital and corporate purposes. The company plans to use the proceeds to achieve key business objectives and demonstrates investor confidence in its data management SaaS solutions for healthcare providers. SCWorx will also issue 277,778 shares to the investor as part of this agreement.
SCWorx Corp (Nasdaq: WORX) has received final court approval for a settlement with the SEC regarding its April 13, 2020 press release. The settlement, without admitting guilt, entails a $125,000 penalty and disgorgement of $471,000 plus prejudgment interest of $32,761.56. To satisfy this, SCWorx will contribute stock valued at $600,000 to affected investors in a private class action. CEO Tim Hannibal emphasizes the resolution of legal issues allows the company to focus on expanding its data management services for healthcare providers.
SCWorx Corp (Nasdaq: WORX) announced a preliminary agreement to address an SEC investigation related to its April 2020 press release. Subject to SEC approval, the company will pay a civil penalty of $125,000 in four installments over one year. The settlement aims to resolve the SEC's enforcement action recommendation, which includes potential fines. SCWorx's CEO emphasizes the importance of focusing on future growth rather than past legal issues. The company continues to provide data management solutions for healthcare providers, ensuring operational efficiency and accurate reporting.
SCWorx Corp. (Nasdaq: WORX) announced the preliminary court approval of a settlement resolving three shareholder derivative lawsuits, consolidated as Lozano v. Schessel et al. The settlement, reached on February 15, 2022, requires the Company's insurers to pay $300,000 for plaintiffs' legal fees, and SCWorx will implement corporate governance reforms. The settlement addresses allegations against current and former directors regarding misleading statements about the sale of COVID-19 rapid test kits. A court hearing is scheduled for June 29, 2022, to finalize the approval.
SCWorx Corp. (Nasdaq: WORX) has secured a 39-month agreement worth approximately $1.1 million with an existing customer, effective from October 1, 2021. This contract will enhance services provided to a respected academic health system in the northeast. The CEO highlighted the company's commitment to evolving its SaaS platform to better integrate clinical and billing data, aiming for improved supply chain visibility. The press release also contains forward-looking statements, underlining potential risks like economic disruptions and contract terminations that could impact future performance.
SCWorx Corp. (Nasdaq: WORX) announced the completion of a stock offering, issuing 298,883 shares and warrants for an aggregate of $535,000 in proceeds. The offering closed on September 17, 2021, with the funds designated for general corporate and working capital purposes. CEO Tim Hannibal highlighted the company's strategy for growth in data management services, especially in supporting healthcare providers amid pandemic challenges. SCWorx plans to enhance operational efficiency and cost savings through its innovative service suite, utilizing machine learning and AI.
SCWorx Corp. (Nasdaq: WORX) has regained compliance with Nasdaq's listing requirements after filing its Annual Report for the year ending December 31, 2020, and holding its Special Meeting on May 24, 2021. As a result, its common stock continues trading on Nasdaq. Tim Hannibal has been promoted to CEO, succeeding his role as President and COO. With a strong background in SaaS, Hannibal aims to enhance the company's growth strategy. The board expresses confidence in his leadership to drive SCWorx's success in leveraging technology for healthcare efficiencies.
SCWorx Corp. (Nasdaq: WORX) announced it has received notifications from Nasdaq regarding non-compliance with listing rules due to the delayed filing of its 2020 10-K report. The initial notification was on April 19, followed by another on April 21, 2021, which extended the compliance deadline to May 19, 2021. The company aims to file the 2020 10-K by May 17, 2021, but will submit a compliance plan if it cannot meet this deadline.